Public

Next Generation Sequencing Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035

by nidhi thankur

Entries 0

Page 1 of 1

Book Description

Roots Analysis recently published a report on the global Next Generation Sequencing Market Size, Share And Growth Trend Analysis Report By Region And Segmentation Forecasts (2026 - 2035) growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.
Market Size and Forecast
Current Market Size:USD 9.8 Billion
Future Market Size: USD 46.5 Billion
CAGR: 18.9%
Market Overview
This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments.
This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration.
Market Scope and Segmentation
- Historical Trend: Since 2020
- Forecast Period: Till 2035
- Current Market Size: USD 9.8 Billion
- Market Size in 2035: USD 46.5 Billion
- CAGR (Till 2035): 18.9%
- Type of Component
• Consumables
• Services
• Instruments
- Type of NGS Technique
• Targeted Sequencing
• / Whole Exome Sequencing
• RNA Sequencing
• Other Techniques
- Type of Technology Used
• Sequencing by Synthesis Technology
• Ion Semiconductor Technology
• Nanopore Sequencing Technology
• Other Technologies
- Application Area
• Clinical Applications
• Research and Applied Applications
- Target Therapeutic Area
• Oncological Disorders
• Genetic Disorders
• Reproductive Disorders
• Other Therapeutic Areas
- Purpose
• Diagnosis
• Risk Assessment
• Presymptomatic Assessment
• Screening
• Other Purposes
- End Users
• Academic and Research Institutes
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Other End Users
- Geographical Regions
• North America
• Europe
• Asia-Pacific
• Middle East and North Africa
• Latin America
- Market in North America
• US
• Canada
- Market in Europe
• Germany
• France
• Italy
• Spain
• UK
• Rest of Europe
- Market in Asia-Pacific
• China
• India
• Japan
• South Korea
• Singapore
• Rest of Asia-Pacific
- Market in Middle East and North Africa
• Egypt
• Israel
• Saudi Arabia
• Rest of Middle East and North Africa
- Market in Latin America
• Brazil
• Argentina
• Rest of Latin America
- Key Next Generation Sequencing Companies Profiled
• Admera Health
• Applied Biological Materials
• BGI Genomics
• CD Genomics
• DNA Link
• Eurofins Genomics
• Gene by Gene
• GENEWIZ
• MedGenome
• Novogene
• Psomagen
• Veritas
• Xcelris Labs
- Key Next-generation Sequencing Technology Providers Profiled
• Illumina
• MGI Tech
• Oxford Nanopore Technologies
• Pacific Biosciences
• Thermo Fisher Scientific
- PowerPoint Presentation(Complimentary): Available
- Customization Scope: 15% Free Customization
- Excel Data Packs(Complimentary)
• Market Landscape (
• Market Landscape (
• Technologies / Platforms Competitive Analysis
• Patent Analysis
• Clinical Trial Analysis
• Big Pharma Analysis
• Case Study Analysis
• Market Forecast and Opportunity Analysis

Read More: https://www.rootsanalysis.com/reports/next-generation-sequencing/290.html

By Region
North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America
This segmentation structure provides a clear framework for understanding market dynamics, segment-specific trends, and growth opportunities.
Technological and Strategic Insights
The Roots Analysis report includes a detailed assessment of:
• Technological advancements and R&D activity
• Innovations in formulation and delivery methods
• Marketing and distribution strategies
• Pricing models and cost structures
• Manufacturing capacities and supply chain trends
These insights are presented neutrally, supported by empirical evidence and primary research validation.
Key Market Players
Profiles of prominent companies include:
Admera Health, Applied Biological Materials, BGI Genomics, CD Genomics, DNA Link, Eurofins Genomics, Gene by Gene, GENEWIZ, MedGenome, Novogene, Psomagen, Veritas, Xcelris Labs
Each profile highlights:
• Product portfolio and focus areas
• Operational footprint and regional presence
• Financial and strategic performance
• Recent developments (e.g., partnerships, market entries, acquisitions)
Regional Insights
Each region is analyzed based on:
• Historical and current market size
• Revenue performance
• Contribution to global share
• Strategic developments and regional trends
Comparative insights across regions enable targeted market entry and expansion strategies.
Report Structure
• Part 01: Market Overview
• Part 02: Market Size, by Regions
• Part 03: Market Revenue, by Countries
• Part 04: Market Competition, by Key Players
• Part 05: Company Profiles